zunsemetinib
oral p38a-MK2 inhibitor Ph. IIa for hidradenitis suppurativa (failed) rational design from ATP-competitive molecule Press release, March 6, 2023 Confluence, MO / Aclaris Therapeutics, PA
Molecules of the Month - March 2023
oral p38a-MK2 inhibitor Ph. IIa for hidradenitis suppurativa (failed) rational design from ATP-competitive molecule Press release, March 6, 2023 Confluence, MO / Aclaris Therapeutics, PA
Molecules of the Month - March 2023